Dialysis patients benefit significantly with the addition of levocarnitine to their dialysis treatments at least once a month, cutting the number of days in the hospital from an average of 15 to roughly ten days. Reuters Health Information
Alemtuzumab is superior to chlorambucil as first-line treatment for patients with chronic lymphocytic leukemia (CLL), according to results of a study published in the December issue of the Journal of Clinical Oncology. Reuters Health Information
Dabigatran (Boehringer Ingelheim), an investigational oral direct thrombin inhibitor, has shown efficacy and safety at defined doses in patients with nonvalvular atrial fibrillation (AF). Reuters Health Information
The dipeptidyl peptidase IV inhibitor vildagliptin (Galvus) is effective monotherapy for treatment-naive elderly patients with type 2 diabetes, according to a report in the December issue of Diabetes Care. Reuters Health Information
